Benitec Biopharma Inc.

13.95
0.29 (2.12%)
At close: Apr 24, 2025, 3:59 PM
13.45
-3.55%
Pre-market: Apr 25, 2025, 04:25 AM EDT

Benitec Biopharma Statistics

Share Statistics

Benitec Biopharma has 25.55M shares outstanding. The number of shares has increased by 172.16% in one year.

Shares Outstanding 25.55M
Shares Change (YoY) 172.16%
Shares Change (QoQ) 9.81%
Owned by Institutions (%) 23.95%
Shares Floating 23.9M
Failed to Deliver (FTD) Shares 45
FTD / Avg. Volume 0.1%

Short Selling Information

The latest short interest is 294.2K, so 1.15% of the outstanding shares have been sold short.

Short Interest 294.2K
Short % of Shares Out 1.15%
Short % of Float 2.17%
Short Ratio (days to cover) 3.97

Valuation Ratios

The PE ratio is -5.42 and the forward PE ratio is -6.26. Benitec Biopharma's PEG ratio is 0.09.

PE Ratio -5.42
Forward PE -6.26
PS Ratio 545.87
Forward PS 3.1
PB Ratio 2.5
P/FCF Ratio -6.02
PEG Ratio 0.09
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Benitec Biopharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.49, with a Debt / Equity ratio of 0.01.

Current Ratio 10.49
Quick Ratio 10.49
Debt / Equity 0.01
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage -24.88

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $13.5K
Profits Per Employee $-1.36M
Employee Count 16
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -619K
Effective Tax Rate 2.77%

Stock Price Statistics

The stock price has increased by 101.01% in the last 52 weeks. The beta is 0.77, so Benitec Biopharma's price volatility has been higher than the market average.

Beta 0.77
52-Week Price Change 101.01%
50-Day Moving Average 12.94
200-Day Moving Average 10.83
Relative Strength Index (RSI) 56.13
Average Volume (20 Days) 43.43K

Income Statement

In the last 12 months, Benitec Biopharma had revenue of 216K and earned -21.75M in profits. Earnings per share was -2.68.

Revenue 216K
Gross Profit 108K
Operating Income -22.49M
Net Income -21.75M
EBITDA -22.49M
EBIT -22.49M
Earnings Per Share (EPS) -2.68
Full Income Statement

Balance Sheet

The company has 50.87M in cash and 284K in debt, giving a net cash position of 50.58M.

Cash & Cash Equivalents 50.87M
Total Debt 284K
Net Cash 50.58M
Retained Earnings -190.26M
Total Assets 79.07M
Working Capital 75.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.4M and capital expenditures -179K, giving a free cash flow of -19.58M.

Operating Cash Flow -19.4M
Capital Expenditures -179K
Free Cash Flow -19.58M
FCF Per Share -1.21
Full Cash Flow Statement

Margins

Gross margin is 50%, with operating and profit margins of -10412.04% and -10069.91%.

Gross Margin 50%
Operating Margin -10412.04%
Pretax Margin -10356.48%
Profit Margin -10069.91%
EBITDA Margin -10412.04%
EBIT Margin -10412.04%
FCF Margin -9065.74%

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for BNTC is $24, which is 72% higher than the current price. The consensus rating is "Buy".

Price Target $24
Price Target Difference 72%
Analyst Consensus Buy
Analyst Count 8
Stock Forecasts

Stock Splits

The last stock split was on Jul 26, 2023. It was a backward split with a ratio of 1:17.

Last Split Date Jul 26, 2023
Split Type backward
Split Ratio 1:17

Scores

Altman Z-Score 64.12
Piotroski F-Score 2